Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Cooper Companies (COO) Competitors

Cooper Companies logo
$61.21 -0.44 (-0.71%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$61.09 -0.12 (-0.20%)
As of 10/23/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

COO vs. ALC, WST, SOLV, ALGN, and BLCO

Should you buy Cooper Companies stock or one of its competitors? Cooper Companies's main competitors and comparable companies include Alcon (ALC), West Pharmaceutical Services (WST), Solventum (SOLV), Align Technology (ALGN), and Bausch + Lomb (BLCO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Cooper Companies compare to Alcon?

Cooper Companies (NASDAQ:COO) and Alcon (NYSE:ALC) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 53.9% of Alcon shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Comparatively, 1.5% of Alcon shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alcon has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B2.84$374.90M$2.9320.89
Alcon$10.40B3.34$980M$1.3153.61

In the previous week, Cooper Companies had 17 more articles in the media than Alcon. MarketBeat recorded 26 mentions for Cooper Companies and 9 mentions for Alcon. Cooper Companies' average media sentiment score of 1.07 beat Alcon's score of 0.49 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
17 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alcon
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cooper Companies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Alcon has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market.

Cooper Companies presently has a consensus price target of $68.60, indicating a potential upside of 12.07%. Alcon has a consensus price target of $82.81, indicating a potential upside of 17.92%. Given Alcon's stronger consensus rating and higher probable upside, analysts plainly believe Alcon is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
2 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.11
Alcon
1 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.61

Cooper Companies has a net margin of 13.46% compared to Alcon's net margin of 5.92%. Cooper Companies' return on equity of 10.90% beat Alcon's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies13.46% 10.90% 7.24%
Alcon 5.92%7.29%5.09%

Summary

Alcon beats Cooper Companies on 10 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

In the previous week, Cooper Companies had 12 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 26 mentions for Cooper Companies and 14 mentions for West Pharmaceutical Services. Cooper Companies' average media sentiment score of 1.07 beat West Pharmaceutical Services' score of 0.50 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
4 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cooper Companies
17 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services has a net margin of 16.98% compared to Cooper Companies' net margin of 13.46%. West Pharmaceutical Services' return on equity of 20.11% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services16.98% 20.11% 14.83%
Cooper Companies 13.46%10.90%7.24%

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$3.07B8.97$493.70M$7.8150.19
Cooper Companies$4.09B2.84$374.90M$2.9320.89

West Pharmaceutical Services has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

West Pharmaceutical Services currently has a consensus target price of $391.17, suggesting a potential downside of 0.21%. Cooper Companies has a consensus target price of $68.60, suggesting a potential upside of 12.07%. Given Cooper Companies' higher possible upside, analysts plainly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.86
Cooper Companies
2 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.11

Summary

West Pharmaceutical Services beats Cooper Companies on 11 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Solventum?

Solventum (NYSE:SOLV) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

In the previous week, Cooper Companies had 18 more articles in the media than Solventum. MarketBeat recorded 26 mentions for Cooper Companies and 8 mentions for Solventum. Cooper Companies' average media sentiment score of 1.07 beat Solventum's score of 0.56 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
17 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Solventum presently has a consensus price target of $92.80, suggesting a potential upside of 8.45%. Cooper Companies has a consensus price target of $68.60, suggesting a potential upside of 12.07%. Given Cooper Companies' higher probable upside, analysts clearly believe Cooper Companies is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.64
Cooper Companies
2 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.11

Solventum has higher revenue and earnings than Cooper Companies. Solventum is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solventum$8.33B1.75$1.56B$8.1810.46
Cooper Companies$4.09B2.84$374.90M$2.9320.89

Solventum has a net margin of 17.26% compared to Cooper Companies' net margin of 13.46%. Solventum's return on equity of 25.09% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Solventum17.26% 25.09% 8.78%
Cooper Companies 13.46%10.90%7.24%

Solventum has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

24.4% of Cooper Companies shares are held by institutional investors. 0.2% of Solventum shares are held by company insiders. Comparatively, 2.1% of Cooper Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Solventum and Cooper Companies tied by winning 8 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Align Technology?

Cooper Companies (NASDAQ:COO) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

Align Technology has lower revenue, but higher earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B2.84$374.90M$2.9320.89
Align Technology$4.03B2.74$410.35M$5.7526.87

Cooper Companies has a net margin of 13.46% compared to Align Technology's net margin of 9.99%. Align Technology's return on equity of 15.86% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies13.46% 10.90% 7.24%
Align Technology 9.99%15.86%10.32%

Cooper Companies currently has a consensus target price of $68.60, suggesting a potential upside of 12.07%. Align Technology has a consensus target price of $190.93, suggesting a potential upside of 23.57%. Given Align Technology's stronger consensus rating and higher probable upside, analysts clearly believe Align Technology is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
2 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.11
Align Technology
1 Sell rating(s)
7 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.53

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 0.8% of Align Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cooper Companies has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, indicating that its stock price is 67% more volatile than the broader market.

In the previous week, Cooper Companies had 2 more articles in the media than Align Technology. MarketBeat recorded 26 mentions for Cooper Companies and 24 mentions for Align Technology. Cooper Companies' average media sentiment score of 1.07 beat Align Technology's score of 0.70 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
17 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Align Technology
11 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Align Technology beats Cooper Companies on 11 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and Cooper Companies (NASDAQ:COO) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Bausch + Lomb currently has a consensus target price of $19.46, indicating a potential upside of 11.58%. Cooper Companies has a consensus target price of $68.60, indicating a potential upside of 12.07%. Given Cooper Companies' higher possible upside, analysts plainly believe Cooper Companies is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
1 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.47
Cooper Companies
2 Sell rating(s)
13 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.11

In the previous week, Cooper Companies had 22 more articles in the media than Bausch + Lomb. MarketBeat recorded 26 mentions for Cooper Companies and 4 mentions for Bausch + Lomb. Cooper Companies' average media sentiment score of 1.07 beat Bausch + Lomb's score of 0.60 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
17 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Bausch + Lomb has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Cooper Companies has a net margin of 13.46% compared to Bausch + Lomb's net margin of -3.21%. Cooper Companies' return on equity of 10.90% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch + Lomb-3.21% 4.14% 1.93%
Cooper Companies 13.46%10.90%7.24%

Cooper Companies has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch + Lomb$5.10B1.22-$360M-$0.48N/A
Cooper Companies$4.09B2.84$374.90M$2.9320.89

Summary

Cooper Companies beats Bausch + Lomb on 13 of the 17 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$11.72B$5.88B$7.63B$12.57B
Dividend YieldN/A1.72%2.48%42.79%
P/E Ratio20.8926.44275.8725.54
Price / Sales2.8469.33539.4462.72
Price / Cash10.1832.7076.2951.34
Price / Book1.485.9210.635.99
Net Income$374.90M$147.49M$3.51B$382.09M
7 Day Performance5.64%0.32%1.17%-0.45%
1 Month Performance10.53%-4.62%-7.57%-7.92%
1 Year Performance-16.73%3.92%1.63%-7.38%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
4.4856 of 5 stars
$61.21
-0.7%
$68.60
+12.1%
-17.9%$11.64B$4.24B20.8915,000
ALC
Alcon
3.75 of 5 stars
$66.58
+0.0%
$83.39
+25.2%
-8.0%$33.05B$10.40B51.0025,942
WST
West Pharmaceutical Services
3.905 of 5 stars
$383.64
+0.2%
$391.17
+2.0%
+27.5%$27.04B$3.07B49.1910,800
SOLV
Solventum
2.4289 of 5 stars
$87.55
-0.4%
$92.80
+6.0%
+18.3%$14.92B$8.33B10.7120,000
ALGN
Align Technology
4.0879 of 5 stars
$150.62
+0.9%
$194.14
+28.9%
+13.6%$10.82B$4.03B26.2720,290

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 10/24/2026 by MarketBeat.com Staff.
From Our Partners